{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T07:15:20Z","timestamp":1768029320518,"version":"3.49.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    N4BP1 specifically degrades a subset of mRNA targets through their coding sequences and functions as a negative regulator of inflammation; however, its role in cancer development remains undefined. N4BP1 exhibits the highest expression in head and neck squamous cell carcinoma among all analyzed cancer types. Unlike wild-type mice,\n                    <jats:italic>N4bp1<\/jats:italic>\n                    <jats:sup>\u2212\/\u2212<\/jats:sup>\n                    mice did not develop visible tongue tumor masses in a 4-NQO-induced oral carcinogenesis model. Furthermore,\n                    <jats:italic>N4bp1<\/jats:italic>\n                    <jats:sup>\u2212\/\u2212<\/jats:sup>\n                    mice (86% vs 0%) exhibited significantly prolonged survival compared to wild-type mice within 26 weeks in 4-NQO-induced oral carcinogenesis model. Single-cell profiling demonstrated that N4BP1-deficient epithelial cells arrest at an early stage of cancerous transformation, while wild-type epithelial cells efficiently progress to an advanced stage of cancer. In established human cancer cell lines, N4BP1 also plays a crucial role in proliferation, migration, colony formation, and in vivo growth. Transcriptome profiling identified CCL2 and GM-CSF as downstream targets of N4BP1 in oral cancer. Apart from its intrinsic role in cancer cells, N4BP1-deficient cancer cells induce the differentiation of macrophages into the M1 phenotype. In N4BP1-deficient tissues, CCL2 and GM-CSF were significantly increased, accompanied by the accumulation of M1 macrophages and neutrophils. Our results demonstrate that N4BP1 is an essential gene in tongue cancer development. N4BP1 not only drives cancer cell evolution but also establishes an immune-suppressive microenvironment. N4BP1 is an endoribonuclease that specifically regulates a subset of mRNA targets (including CCL2 and GM-CSF) and plays an essential role in oral cancer.\n                  <\/jats:p>","DOI":"10.1038\/s41419-025-08229-0","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T14:41:53Z","timestamp":1767969713000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["N4BP1 is essential for the development of oral cancer via controlling both cancer cells and immune microenvironment"],"prefix":"10.1038","volume":"17","author":[{"given":"Yihua","family":"Song","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanli","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liuting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanyuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miaomiao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingmei","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3372-1069","authenticated-orcid":false,"given":"Mingbing","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8465-1614","authenticated-orcid":false,"given":"Renfang","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6372-4765","authenticated-orcid":false,"given":"Yihui","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,9]]},"reference":[{"key":"8229_CR1","first-page":"87","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87\u2013108.","journal-title":"CA Cancer J Clin"},{"key":"8229_CR2","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.semcancer.2019.09.011","volume":"61","author":"AWY Chai","year":"2020","unstructured":"Chai AWY, Lim KP, Cheong SC. Translational genomics and recent advances in oral squamous cell carcinoma. Semin Cancer Biol. 2020;61:71\u201383.","journal-title":"Semin Cancer Biol"},{"key":"8229_CR3","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1126\/science.1206923","volume":"333","author":"N Agrawal","year":"2011","unstructured":"Agrawal N, Frederick MJ, Pickering CR, Bettegowda C, Chang K, Li RJ, et al. Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science. 2011;333:1154\u20137.","journal-title":"Science"},{"key":"8229_CR4","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1126\/science.1208130","volume":"333","author":"N Stransky","year":"2011","unstructured":"Stransky N, Egloff AM, Tward AD, Kostic AD, Cibulskis K, Sivachenko A, et al. The mutational landscape of head and neck squamous cell carcinoma. Science. 2011;333:1157\u201360.","journal-title":"Science"},{"key":"8229_CR5","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/bs.mcb.2020.09.004","volume":"163","author":"J Bouaoud","year":"2021","unstructured":"Bouaoud J, De Souza G, Darido C, Tortereau A, Elkabets M, Bertolus C, et al. The 4-NQO mouse model: an update on a well-established in vivo model of oral carcinogenesis. Methods Cell Biol. 2021;163:197\u2013229.","journal-title":"Methods Cell Biol"},{"key":"8229_CR6","first-page":"11884","volume":"8","author":"C Rivera","year":"2015","unstructured":"Rivera C. Essentials of oral cancer. Int J Clin Exp Pathol. 2015;8:11884\u201394.","journal-title":"Int J Clin Exp Pathol"},{"key":"8229_CR7","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/s41568-023-00660-9","volume":"24","author":"S Yuan","year":"2024","unstructured":"Yuan S, Almagro J, Fuchs E. Beyond genetics: driving cancer with the tumour microenvironment behind the wheel. Nat Rev Cancer. 2024;24:274\u201386.","journal-title":"Nat Rev Cancer"},{"key":"8229_CR8","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1002\/ijc.1407","volume":"93","author":"C Liss","year":"2001","unstructured":"Liss C, Fekete MJ, Hasina R, Lam CD, Lingen MW. Paracrine angiogenic loop between head-and-neck squamous-cell carcinomas and macrophages. Int J Cancer. 2001;93:781\u20135.","journal-title":"Int J Cancer"},{"key":"8229_CR9","doi-asserted-by":"publisher","first-page":"2779","DOI":"10.1002\/cncr.20701","volume":"101","author":"B Marcus","year":"2004","unstructured":"Marcus B, Arenberg D, Lee J, Kleer C, Chepeha DB, Schmalbach CE, et al. Prognostic factors in oral cavity and oropharyngeal squamous cell carcinoma. Cancer. 2004;101:2779\u201387.","journal-title":"Cancer"},{"key":"8229_CR10","doi-asserted-by":"publisher","first-page":"8026","DOI":"10.1158\/0008-5472.CAN-06-0158","volume":"66","author":"CM Gutschalk","year":"2006","unstructured":"Gutschalk CM, Herold-Mende CC, Fusenig NE, Mueller MM. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor promote malignant growth of cells from head and neck squamous cell carcinomas in vivo. Cancer Res. 2006;66:8026\u201336.","journal-title":"Cancer Res"},{"key":"8229_CR11","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1002\/(SICI)1097-0215(19991210)83:6<780::AID-IJC14>3.0.CO;2-C","volume":"83","author":"MM Mueller","year":"1999","unstructured":"Mueller MM, Fusenig NE. Constitutive expression of g-CSF and GM-CSF in human skin carcinoma cells with functional consequence for tumor progression. Int J Cancer. 1999;83:780\u20139.","journal-title":"Int J Cancer"},{"key":"8229_CR12","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1007\/s10585-009-9281-8","volume":"26","author":"M Takahashi","year":"2009","unstructured":"Takahashi M, Miyazaki H, Furihata M, Sakai H, Konakahara T, Watanabe M, et al. Chemokine CCL2\/MCP-1 negatively regulates metastasis in a highly bone marrow-metastatic mouse breast cancer model. Clin Exp Metastasis. 2009;26:817\u201328.","journal-title":"Clin Exp Metastasis"},{"key":"8229_CR13","doi-asserted-by":"publisher","first-page":"2780","DOI":"10.1200\/JCO.2014.58.3377","volume":"33","author":"RHI Andtbacka","year":"2015","unstructured":"Andtbacka RHI, Kaufman HL, Collichio F, Amatruda T, Senzer N, Chesney J, et al. Talimogene laherparepvec improves durable response rate in patients with advanced melanoma. J Clin Oncol. 2015;33:2780\u20138.","journal-title":"J Clin Oncol"},{"key":"8229_CR14","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/2051-1426-2-11","volume":"2","author":"HL Kaufman","year":"2014","unstructured":"Kaufman HL, Ruby CE, Hughes T, Slingluff CLJ. Current status of granulocyte-macrophage colony-stimulating factor in the immunotherapy of melanoma. J Immunother Cancer. 2014;2:11.","journal-title":"J Immunother Cancer"},{"key":"8229_CR15","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1080\/15216540400022441","volume":"56","author":"SR Kushner","year":"2004","unstructured":"Kushner SR. MRNA decay in prokaryotes and eukaryotes: different approaches to a similar problem. IUBMB Life. 2004;56:585\u201394.","journal-title":"IUBMB Life"},{"key":"8229_CR16","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1080\/10409230490513991","volume":"39","author":"S Meyer","year":"2004","unstructured":"Meyer S, Temme C, Wahle E. Messenger RNA turnover in eukaryotes: pathways and enzymes. Crit Rev Biochem Mol Biol. 2004;39:197\u2013216.","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"8229_CR17","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1261\/rna.2237610","volume":"16","author":"R Tomecki","year":"2010","unstructured":"Tomecki R, Dziembowski A. Novel endoribonucleases as central players in various pathways of eukaryotic RNA metabolism. RNA. 2010;16:1692\u2013724.","journal-title":"RNA"},{"key":"8229_CR18","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/cmi.2016.70","volume":"14","author":"R Mao","year":"2017","unstructured":"Mao R, Yang R, Chen X, Harhaj EW, Wang X, Fan Y. Regnase-1, a rapid response ribonuclease regulating inflammation and stress responses. Cell Mol Immunol. 2017;14:412\u201322.","journal-title":"Cell Mol Immunol"},{"key":"8229_CR19","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/imr.13023","volume":"304","author":"T Mino","year":"2021","unstructured":"Mino T, Takeuchi O. Regnase-1-related endoribonucleases in health and immunological diseases. Immunol Rev. 2021;304:97\u2013110.","journal-title":"Immunol Rev"},{"key":"8229_CR20","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1038\/nature07924","volume":"458","author":"K Matsushita","year":"2009","unstructured":"Matsushita K, Takeuchi O, Standley DM, Kumagai Y, Kawagoe T, Miyake T, et al. Zc3h12a is an RNase essential for controlling immune responses by regulating mRNA decay. Nature. 2009;458:1185\u201390.","journal-title":"Nature"},{"key":"8229_CR21","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/j.cell.2015.04.029","volume":"161","author":"T Mino","year":"2015","unstructured":"Mino T, Murakawa Y, Fukao A, Vandenbon A, Wessels H, Ori D, et al. Regnase-1 and roquin regulate a common element in inflammatory mRNAs by spatiotemporally distinct mechanisms. Cell. 2015;161:1058\u201373.","journal-title":"Cell"},{"key":"8229_CR22","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1038\/s41590-021-01064-3","volume":"22","author":"G Behrens","year":"2021","unstructured":"Behrens G, Edelmann SL, Raj T, Kronbeck N, Monecke T, Davydova E, et al. Disrupting roquin-1 interaction with regnase-1 induces autoimmunity and enhances antitumor responses. Nat Immunol. 2021;22:1563\u201376.","journal-title":"Nat Immunol"},{"key":"8229_CR23","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/s41586-019-1821-z","volume":"576","author":"J Wei","year":"2019","unstructured":"Wei J, Long L, Zheng W, Dhungana Y, Lim SA, Guy C, et al. Targeting REGNASE-1 programs long-lived effector t cells for cancer therapy. Nature. 2019;576:471\u20136.","journal-title":"Nature"},{"key":"8229_CR24","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/s41586-020-2796-5","volume":"587","author":"AD Gitlin","year":"2020","unstructured":"Gitlin AD, Heger K, Schubert AF, Reja R, Yan D, Pham VC, et al. Integration of innate immune signalling by caspase-8 cleavage of n4BP1. Nature. 2020;587:275\u201380.","journal-title":"Nature"},{"key":"8229_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03774-w","volume":"12","author":"C Gou","year":"2021","unstructured":"Gou C, Ni W, Ma P, Zhao F, Wang Z, Sun R, et al. The endoribonuclease n4BP1 prevents psoriasis by controlling both keratinocytes proliferation and neutrophil infiltration. Cell Death Dis. 2021;12:488.","journal-title":"Cell Death Dis"},{"key":"8229_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21711-5","volume":"12","author":"H Shi","year":"2021","unstructured":"Shi H, Sun L, Wang Y, Liu A, Zhan X, Li X, et al. N4BP1 negatively regulates NF-kappab by binding and inhibiting NEMO oligomerization. Nat Commun. 2021;12:1379.","journal-title":"Nat Commun"},{"key":"8229_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2023.110850","volume":"110","author":"C Wu","year":"2023","unstructured":"Wu C, Guo X, Zheng W, Sun R, Chen L, Shen Y, et al. N4BP1 regulates keratinocytes development and plays protective role in burn- and adhesive-related skin injury via MMP9. Cell Signal. 2023;110:110850.","journal-title":"Cell Signal"},{"key":"8229_CR28","doi-asserted-by":"publisher","first-page":"6621","DOI":"10.1158\/0008-5472.CAN-18-0545","volume":"78","author":"L Spel","year":"2018","unstructured":"Spel L, Nieuwenhuis J, Haarsma R, Stickel E, Bleijerveld OB, Altelaar M, et al. Nedd4-binding protein 1 and TNFAIP3-interacting protein 1 control MHC-1 display in neuroblastoma. Cancer Res. 2018;78:6621\u201331.","journal-title":"Cancer Res"},{"key":"8229_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1769-9","volume":"10","author":"E Alsahafi","year":"2019","unstructured":"Alsahafi E, Begg K, Amelio I, Raulf N, Lucarelli P, Sauter T, et al. Clinical update on head and neck cancer: molecular biology and ongoing challenges. Cell Death Dis. 2019;10:540.","journal-title":"Cell Death Dis"},{"key":"8229_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-53390-3","volume":"15","author":"T Muijlwijk","year":"2024","unstructured":"Muijlwijk T, Nauta IH, van der Lee A, Grunewald KJT, Brink A, Ganzevles SH, et al. Hallmarks of a genomically distinct subclass of head and neck cancer. Nat Commun. 2024;15:9060.","journal-title":"Nat Commun"},{"key":"8229_CR31","doi-asserted-by":"publisher","first-page":"7267","DOI":"10.1016\/j.cell.2024.09.046","volume":"187","author":"K Punovuori","year":"2024","unstructured":"Punovuori K, Bertillot F, Miroshnikova YA, Binner MI, Myllymaki S, Follain G, et al. Multiparameter imaging reveals clinically relevant cancer cell-stroma interaction dynamics in head and neck cancer. Cell. 2024;187:7267\u201384.","journal-title":"Cell"},{"key":"8229_CR32","volume":"29","author":"Y Osawa","year":"2021","unstructured":"Osawa Y, Aoyama K, Hosomichi K, Uchibori M, Tajima A, Kimura M, et al. Somatic mutations in oral squamous cell carcinomas in 98 Japanese patients and their clinical implications. Cancer Treat Res Commun. 2021;29:100456.","journal-title":"Cancer Treat Res Commun"},{"key":"8229_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2024.107078","volume":"159","author":"HF Pelaez-Prestel","year":"2024","unstructured":"Pelaez-Prestel HF, Gonzalez-Martin F, Ras-Carmona A, Rocha A, Cabanas C, Lafuente EM, et al. Oral squamous cell carcinomas drive monocytes into immunosuppressive CD25(+)CD163(+)CD206(+) macrophages. Oral Oncol. 2024;159:107078.","journal-title":"Oral Oncol"},{"key":"8229_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19401-9","volume":"11","author":"I Sequeira","year":"2020","unstructured":"Sequeira I, Rashid M, Tomas IM, Williams MJ, Graham TA, Adams DJ, et al. Genomic landscape and clonal architecture of mouse oral squamous cell carcinomas dictate tumour ecology. Nat Commun. 2020;11:5671.","journal-title":"Nat Commun"},{"key":"8229_CR35","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/s41392-024-01848-7","volume":"9","author":"S Zhang","year":"2024","unstructured":"Zhang S, Xiao X, Yi Y, Wang X, Zhu L, Shen Y, et al. Tumor initiation and early tumorigenesis: molecular mechanisms and interventional targets. Signal Transduct Target Ther. 2024;9:149.","journal-title":"Signal Transduct Target Ther"},{"key":"8229_CR36","doi-asserted-by":"publisher","first-page":"410","DOI":"10.18632\/oncoscience.140","volume":"2","author":"J Lee","year":"2015","unstructured":"Lee J, Wysocki PT, Topaloglu O, Maldonado L, Brait M, Begum S, et al. Epigenetic silencing of s100A2 in bladder and head and neck cancers. Oncoscience. 2015;2:410\u20138.","journal-title":"Oncoscience"},{"key":"8229_CR37","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1007\/s00726-010-0623-2","volume":"41","author":"S Wolf","year":"2011","unstructured":"Wolf S, Haase-Kohn C, Pietzsch J. S100A2 in cancerogenesis: a friend or a foe?. Amino Acids. 2011;41:849\u201361.","journal-title":"Amino Acids"},{"key":"8229_CR38","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1007\/s12070-011-0359-7","volume":"66","author":"Z Huang","year":"2014","unstructured":"Huang Z, Li W, Lin S, Fang X, Zhang C, Liao Z. Identification of novel tumor suppressor genes down-regulated in recurrent nasopharyngeal cancer by DNA microarray. Indian J Otolaryngol Head Neck Surg. 2014;66:120\u20135.","journal-title":"Indian J Otolaryngol Head Neck Surg"},{"key":"8229_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-014-0369-9","volume":"13","author":"M Kumar","year":"2015","unstructured":"Kumar M, Srivastava G, Kaur J, Assi J, Alyass A, Leong I, et al. Prognostic significance of cytoplasmic s100A2 overexpression in oral cancer patients. J Transl Med. 2015;13:8.","journal-title":"J Transl Med"},{"key":"8229_CR40","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s13045-020-00927-w","volume":"13","author":"H Qin","year":"2020","unstructured":"Qin H, Ni H, Liu Y, Yuan Y, Xi T, Li X, et al. RNA-binding proteins in tumor progression. J Hematol Oncol. 2020;13:90.","journal-title":"J Hematol Oncol"},{"key":"8229_CR41","doi-asserted-by":"publisher","DOI":"10.1126\/science.abl7207","volume":"378","author":"Q Zeng","year":"2022","unstructured":"Zeng Q, Saghafinia S, Chryplewicz A, Fournier N, Christe L, Xie Y, et al. Aberrant hyperexpression of the RNA binding protein FMRP in tumors mediates immune evasion. Science. 2022;378:eabl7207.","journal-title":"Science"},{"key":"8229_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2024.107954","volume":"300","author":"W Zheng","year":"2024","unstructured":"Zheng W, Guo J, Ma S, Sun R, Song Y, Chen Y, et al. The NEDD4-binding protein n4BP1 degrades mRNA substrates through the coding sequence independent of nonsense-mediated decay. J Biol Chem. 2024;300:107954.","journal-title":"J Biol Chem"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08229-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08229-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08229-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T03:02:17Z","timestamp":1768014137000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08229-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,9]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8229"],"URL":"https:\/\/doi.org\/10.1038\/s41419-025-08229-0","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,9]]},"assertion":[{"value":"20 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All authors have agreed to publish this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"This study was approved by the Ethics Committee of Affiliated Hospital of Nantong University (approval number: 2024-K025-01). Patients were consented by an informed consent process that was reviewed by the Ethics Committee of Affiliated Hospital of Nantong University and certified that the study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki. All protocols in this study were approved by the Committee on the Ethics of Laboratory Animal Center of Nantong University (approval number: S20240307-011), in compliance with the Guide for the Care and Use of Laboratory Animals published by the NIH.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent was obtained from all subjects and their legal guardian(s).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"23"}}